TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,872 Cr | ₹2,673 Cr | ₹2,352 Cr | ₹1,847 Cr | ₹1,226 Cr |
What is the latest Profit Before Tax of TORRENT PHARMACEUTICALS ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹2,872 Cr |
| Mar2025 | ₹2,673 Cr |
| Mar2024 | ₹2,352 Cr |
| Mar2023 | ₹1,847 Cr |
| Mar2022 | ₹1,226 Cr |
How is Profit Before Tax of TORRENT PHARMACEUTICALS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,872 Cr | 7.46 | |
| Mar2025 | ₹2,673 Cr | 13.63 | |
| Mar2024 | ₹2,352 Cr | 27.34 | |
| Mar2023 | ₹1,847 Cr | 50.68 | |
| Mar2022 | ₹1,226 Cr | - | |
Compare Profit Before Tax of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹165,929.4 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| MANKIND PHARMA | ₹104,275.0 Cr | -0.6% | 6.5% | 7.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.7% |
9.9% |
46.8% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses